Showing results (731-740 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|July 13, 2006
Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesisKai-Da Wu, Li Zhou, Douglas Burtrum, et al.Cancer Immunology, Immunotherapy : CII|July 20, 2006
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot studyHirohito Kobayashi, Yoshimasa Tanaka, Junji Yagi, et al.Cancer Immunology, Immunotherapy : CII|July 20, 2006
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cellsIl-Kang Na, Ulrich Keilholz, Anne Letsch, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Association between allo-immunoreactive and xeno-immunoreactive subunits of a glycoprotein tumor-associated antigenD M Euhus, R K Gupta, D L MortonCancer Immunology, Immunotherapy : CII|September 9, 2006
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccinationTeresa Cabrera, Ester Lara, José M Romero, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancerT Morita, A Tokue, N MinatoCancer Immunology, Immunotherapy : CII|July 12, 2008
Dendritic cell vaccination and immune monitoringE H J G Aarntzen, C G Figdor, G J Adema, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2007
Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escapeMichal Smahel, Pavla Tejklova, Jana Smahelova, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2007
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent mannerSheraz Yaqub, Karen Henjum, Milada Mahic, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2007
Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunityLaura A Payton, Jennifer D Lewis, Jennifer A Byrne, et al.Pageof 650